Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

EMBO Journal

Volumn 23, Issue 7, 2004, Pages 1669-1678

  Oshima, Hiroko ^a   Oshima, Masanobu ^a   Inaba, Kayo ^a   Taketo, Makoto M ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

COX 2; Gastric hyperplasia; Helicobacter; Macrophages; mPGES 1

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; HELICOBACTER INFECTION; HYPERPLASIA; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH GLAND; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HYPERPLASIA; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, TRANSGENIC; MICROSOMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, IMMUNOLOGIC; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; MUS MUSCULUS;

EID: 2342587509     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600170     Document Type: Article

References (52)

1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545
2. Brembeck FH, Moffett J, Wang TC, Rustgi AK (2001) The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology 120: 1720-1728
3. Cavaillon JM (1994) Cytokines and macrophages. Biomed Pharmacother 48: 445-453
4. Correa P (2003) Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 12: 238s-241s
5. Correa P, Fontham ETH, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Mera R (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92: 1881-1888
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867
7. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI (1991) Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477
8. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow W-H, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni Jr JF, Blot WJ (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7: 97-102
9. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC (1996) Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110: 155-166
10. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT (1999) Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116: 1319-1329
11. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T, Fukamachi H, Noda M (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33: 375-381
12. Homey B, Muller A, Zlotnik A (2002) Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2: 175-184
13. Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58: 1208-1216
14. IARC (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori, Vol 61, Lyon, France: IARC
15. Jüttner S, Cramer T, Wessler S, Walduck A, Gao F, Schmitz F, Wunder C, Weber M, Fischer SM, Schmidt WE, Wiedenmann B, Meyer TF, Naumann M, Höcker M (2003) Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors. Cell Microbiol 5: 821-834
16. Kaisho T, Akira S (2002) Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589: 1-13
17. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K (2001) Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382-4389
18. Kim TI, Lee YC, Lee KH, Han JH, Chon CY, Moon YM, Kang JK, Park IS (2001) Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis,cell proliferation, and inflammatory activity. Infect Immun 69: 5056-5063
19. Knight B, Yeoh GCT, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N (2000) Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192: 1809-1818
20. Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, Karczewska E, Marlicz K, Stachura J, Hahn EG (2001) Expression of hepatocytes growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment Pharmacol Ther 15: 989-999
21. Kuper H, Adami H-O, Trichopoulos D (2000) Infections as a major preventable cause of human cancer. J Intern Med 248: 171-183
22. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B (2001) Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 194: 855-861
23. Lazarus M, Kubata BK, Eguchi N, Fujitani Y, Urade Y, Hayaishi O (2002) Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch Biochem Biophys 397: 336-341
24. Lee A, Fox JG, Otto G, Murphy J (1990) A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99: 1315-1323
25. Lee A, O'Rourke J, de Ungria MC, Robertson B, Daskalopoulos G, Dixon MF (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397
26. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 5: 828-831
27. Muller WA (2001) New mechanisms and pathways for monocyte recruitment. J Exp Med 194: F47-F51
28. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792
29. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJH, Tytgat GNJ (1994) Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29: 425-429
30. δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809
31. δ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61: 1733-1740
32. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8: 289-293
33. Peterson RA, Danon SJ, Eaton KA (2001) Comparison of gastritis and gastric epithelial proliferation in Helicobacter heilmannii-infected nude and BALB/c mice. Vet Pathol 38: 173-183
34. Reinhart WH, Muller O, Halter F (1983) Influence of long-term 16, 16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology 85: 1003-1010
35. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280
36. Roth KA, Kapadia SB, Martin SM, Lorenz RG (1999) Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J Immunol 163: 1490-1497
37. δ716 mouse intestinal polyps. Cancer Res 62: 506-511
38. 2 in human colon cancer cells. Cancer Res 58: 362-366
39. Sheng H, Shao J, Washington MK, DuBois RN (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081
40. δ716 knockout mice. Nat Med 7: 1048-1051
41. 2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur J Cancer 33: 1508-1512
42. Smith Jr MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB (2003) Toll-like receptor (TLR)2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J Biol Chem 278: 32552-32560
43. Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H (2001) Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res 61: 6356-6359
44. Sung JJY, Leung WK, Go MYY, To KF, Cheng ASL, Ng EKW, Chan FKL (2000) Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157: 729-735
45. Taketo MM (1998a) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90: 1529-1536
46. Taketo MM (1998b) Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 90: 1609-1620
47. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath Jr CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
48. Voisin L, Breuille D, Ruot B, Ralliere C, Rambourdin F, Dalle M, Obled C (1998) Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol 275: R1412-R1419
49. Xiao F, Furuta T, Takashima M, Shirai N, Hanai H (2001) Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice. Aliment Pharmacol Ther 15: 875-886
50. Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson P-J, DeLellis RA, Subbaramaiah K, Dannenberg AJ (2001) Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 7: 3971-3976
51. Zavros Y, Rieder G, Ferguson A, Merchant JL (2002b) Gastritis and hypergastrinemia due to Acinetobacter Iwoffii in mice. Infect Immun 70: 2630-2639
52. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL (2002a) Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122: 119-133